Watchmaker, P., Choe, J., Simic, M., Gilbert, R., li, A., Krasnow, N., . . . Okada, H. (2020). IMMU-33. MULTI-ANTIGEN RECOGNITION CIRCUITS OVERCOME CHALLENGES OF SPECIFICITY, HETEROGENEITY, AND DURABILITY IN T-CELL THERAPY FOR GLIOBLASTOMA. Neuro Oncol.
Chicago-tyylinen lähdeviittausWatchmaker, Payal, et al. "IMMU-33. MULTI-ANTIGEN RECOGNITION CIRCUITS OVERCOME CHALLENGES OF SPECIFICITY, HETEROGENEITY, AND DURABILITY IN T-CELL THERAPY FOR GLIOBLASTOMA." Neuro Oncol 2020.
MLA-viiteWatchmaker, Payal, et al. "IMMU-33. MULTI-ANTIGEN RECOGNITION CIRCUITS OVERCOME CHALLENGES OF SPECIFICITY, HETEROGENEITY, AND DURABILITY IN T-CELL THERAPY FOR GLIOBLASTOMA." Neuro Oncol 2020.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.